Skip to main content
Premium Trial:

Request an Annual Quote

Nirmidas Closes $2M Funding Round

Premium

NEW YORK (GenomeWeb) – Stanford biosensing spin-out Nirmidas Biotech said this week that it has closed on a $2 million seed funding round.

According to the company, participants in the round include a leading venture capital fund, a life science angel investor, and the Stanford StartX Fund.

Nirmidas is developing a plasmonic gold chip platform for biomolecule detection and the detection of proteins in particular.

The technology comes out of the lab of Stanford researcher Hongjie Dai, who co-founded Nirmidas with CEO Meijie Tang, formerly a researcher at Lawrence Livermore National Laboratory. Currently operating with five employees, the company incorporated in September 2013 and began production of its initial research-focused chips in March this year.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.